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The transcriptional co-activators YAP and TAZ are
downstream targets inhibited by the Hippo tumor suppres-
sor pathway. YAP and TAZ both possess WW domains,
which are important protein–protein interaction modules
that mediate interaction with proline-rich motifs, most
commonly PPXY. The WW domains of YAP have
complex regulatory roles as exempliﬁed by recent reports
showing that they can positively or negatively inﬂuence
YAP activity in a cell and context-speciﬁc manner. In this
study, we show that the WW domain of TAZ is important
for it to transform both MCF10A and NIH3T3 cells and to
activate transcription of ITGB2 but not CTGF, as
introducing point mutations into the WW domain of TAZ
(WWm) abolished its transforming and transcription-
promoting ability. Using a proteomic approach, we
discovered potential regulatory proteins that interact with
TAZ WW domain and identiﬁed Wbp2. The interaction of
Wbp2 with TAZ is dependent on the WW domain
of TAZ and the PPXY-containing C-terminal region of
Wbp2. Knockdown of endogenous Wbp2 suppresses,
whereas overexpression of Wbp2 enhances, TAZ-driven
transformation. Forced interaction of WWm with Wbp2 by
direct C-terminal fusion of full-length Wbp2 or its TAZ-
interacting C-terminal domain restored the transforming
and transcription-promoting ability of TAZ. These results
suggest that the WW domain-mediated interaction with
Wbp2 promotes the transforming ability of TAZ.
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Introduction
The Salvador/Warts/Hippo (Hippo) tumor suppressor
pathway originally deﬁned in Drosophila melanogaster is
emerging as a conserved mechanism to regulate cell
proliferation and organogenesis (Harvey and Tapon,
2007; Saucedo and Edgar, 2007; Zeng and Hong,
2008). The major function of the Hippo core compo-
nents is to inactivate the transcriptional co-activator
Yorkie in the ﬂy, and YAP and TAZ in mammals. The
core components of the Hippo pathway consist of
Hippo, Salvador, Warts and Mats in the ﬂy, and
Mst1/2, WW45, LATS1/2 and Mob, respectively, in
mammals (Harvey and Tapon, 2007; Pan, 2007;
Saucedo and Edgar, 2007). Hippo/Mst1/2 and
Salvador/WW45 form a protein kinase complex whose
activity is regulated by cell–cell contact and organ
size. Upon activation, this kinase complex phosphor-
ylates and activates another protein kinase complex
formed by Warts/LATS1/2 and Mats/Mob1. The
activated Warts–Mats and LATS1/2–Mob1 complex
then phosphorylates Yorkie in the ﬂy, and YAP and
TAZ in mammals, respectively, at Ser residues of the
HXRXXS consensus sites, leading to cytoplasmic
sequestration through interaction with 14-3-3 proteins
and thus inactivation of these transcriptional co-
activators (Kanai et al., 2000; Zhao et al., 2007).
Dissociation of Yorkie, YAP and TAZ from 14-3-3
proteins allows them to be translocated into the nucleus
to activate transcriptional programs that promote
cell proliferation and suppress apoptosis. Within the
nucleus, Yorkie interacts with the Scalloped and
Homothorax transcription factors and possibly others
to mediate transcriptional programing (Bandura
and Edgar, 2008; Goulev et al., 2008; Wu et al., 2008;
Peng et al., 2009). Similarly, the scalloped-homologues,
TEAD1–4, are transcription factors that interact
with YAP and TAZ in mammals to drive the functional
outcome of YAP and TAZ (Vassilev et al., 2001;
Mahoney et al., 2005; Zhao et al., 2008, 2009;
Chan et al., 2009). The cell cycle regulator cyclin
E, antiapoptotic DIAP1 and the bantam microRNA
are among the best-characterized downstream targets
of Yorkie, although it is unclear whether cyclin E is a
direct Yorkie target gene (Huang et al., 2005; Nolo
et al., 2006; Tapon et al., 2002; Thompson and Cohen,
2006).
Mutation of core components of the Hippo pathway
or overexpression of Yorkie in the ﬂy leads to tissue
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to apoptosis (Harvey and Tapon, 2007; Saucedo
and Edgar, 2007). Consistent with a protissue growth
role of Yorkie in the ﬂy, YAP and TAZ are candidate
oncogenes in mammals. The chromosome region con-
taining YAP is ampliﬁed in mouse liver and mammary
tumors, as well as in several human cancers (Overholtzer
et al., 2006; Zender et al., 2006; Steinhardt et al., 2008).
YAP protein is also overexpressed in several human
cancers such as hepatocellular carcinoma (Lam-Himlin
et al., 2006; Goulev et al., 2008). Overexpression of YAP
in non-transformed human MCF10A mammary
epithelial cells causes epithelial–mesenchymal transition
(EMT), suppression of apoptosis, growth factor-
independent proliferation and anchorage-independent
growth in soft agar (Overholtzer et al., 2006). Trans-
genic overexpression of YAP in mouse liver causes
tissue enlargement and eventually hepatocellular
carcinoma (Dong et al., 2007). TAZ protein is over-
expressed in a signiﬁcant fraction of primary breast
cancers and its expression levels in breast cancer cell
lines correlate with cell invasiveness (Chan et al., 2008).
Furthermore, expression proﬁling experiments have also
shown that the transcript levels of TAZ and its
interacting partner, TEAD4, are increased in the basal
(or triple negative) breast cancer type (Richardson et al.,
2006; Han et al., 2008). Functionally, like YAP, TAZ
promotes EMT, cell migration, invasion, proliferation
and tumorigenesis (Chan et al., 2008; Lei et al., 2008,
2009, 2009a).
TAZ contains a conserved WW domain that mediates
interaction with PPXY motifs (Sudol et al., 1995; Chen
et al., 1997), whereas the predominant form of YAP
contains two WW domains. In three recent studies, the
functional role of the Yorkie and YAP WW domains
was investigated and found to confer cell and context-
speciﬁc regulation (Oh and Irvine, 2009; Zhao et al.,
2009; Zhang et al., 2009b). The WW domains of YAP
and Yorkie were essential for their ability to transform
NIH-3T3 cells and promote growth of Drosophila
imaginal discs, respectively, suggesting that the WW
domains interact with proteins that enhance Yorkie/
YAP activity but the nature of these factors remains
elusive (Zhao et al., 2009; Zhang et al., 2009b). By
contrast, in MCF10A cells, mutation of the WW
domains increased YAP’s ability to transform MCF10A
cells, suggesting that in this cell type the WW domains
mediate primarily negative regulatory interactions
(Zhang et al., 2009b). As many proteins other than 14-
3-3 and TEAD proteins interact with YAP and/or TAZ
(Wang et al., 2009), this seeming controversy likely
reﬂects the fact that WW domains mediate a complex
network of interactions with proteins that inhibit or
promote Yorkie/YAP activity in cell and context-
speciﬁc manners. This apparent complex regulation
prompted us to examine the regulatory role of the
WW domain of TAZ. Our results suggest that the WW
domain of TAZ is important for its transforming
potential and that Wbp2 is likely to be the key protein
that interacts with the TAZ WW domain to facilitate its
transforming ability.
Results
The WW domain of TAZ is critical for its ability to
transform MCF10A cells
Our earlier studies have shown that TAZ is able to
promote migration, invasion and is important for the
transformed phenotypes of breast cancer cells (Chan
et al., 2008). Anchorage-independent growth of immor-
talized MCF10A cells in soft agar has been used to
assess the tumorigenic property of TAZ, and it was
shown that interaction of TAZ with TEAD transcrip-
tional factors is important for the transforming ability
(Chan et al., 2009). To investigate the importance of the
WW domain of TAZ, a WW domain mutant of TAZ
(WWm) was created and examined. As shown in Figures
1a–c, MCF10A cells transduced with WWm formed
signiﬁcantly fewer colonies as compared with cells
expressing wild-type TAZ. Consistently with earlier
results, the Hippo-refractory mutant TAZ-S89A dis-
played enhanced transforming ability (Chan et al.,
2009). These results suggest that the WW domain is
important for the transforming activity of TAZ.
The WW domain of TAZ is required for transcriptional
activation of ITGB2 but not CTGF
TAZ shares several properties with YAP and there is a
signiﬁcant overlap among the genes that are activated by
TAZ and YAP based on microarray analysis. Among
the genes that are upregulated by both TAZ and YAP in
a TEAD-dependent manner are ITGB2 and CTGF
(Zhang et al., 2009a). It was shown that upregulation of
ITGB2, but not CTGF, by YAP is dependent on the
WW domains (Zhao et al., 2009). We thus assessed the
transcript levels of ITGB2 and CTGF in MCF10A cells
transduced with vector, TAZ, its activating mutant
S89A or WWm. As shown in Figures 1d and e, TAZ
induced activation of both ITGB2 and CTGF. The
induction was further enhanced by the S89A mutation.
However, the induction of ITGB2, but not CTGF, was
compromised for WWm. The ability of WWm to
activate transcription of CTGF suggests that there is
no major conformational or folding change for this
TAZ mutant. This result is consistent with an earlier
report showing that YAP-induced upregulation of
ITGB2, but not CTGF, is dependent on the YAP WW
domains (Zhao et al., 2009).
Wbp2 interacts with TAZ in a WW domain-dependent
manner
To identify proteins that are potential interacting
partners of TAZ in a WW domain-dependent manner,
we performed a large scale coimmunoprecipitation to
identify the interacting proteins of TAZ (Figure 2a).
Among the predominant proteins coimmunprecipitated
by TAZ, S89A and WWm were various 14-3-3 protein
isoforms, which were over-represented in the WWm
coimmunoprecipitation as compared with S89A. Visual
examination of amino-acid sequences of other coim-
munoprecipitated proteins revealed several PPXY motif-
containing proteins, including angiomotin (Amot),
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Oncogeneangiomotin L1 (AmotL1), Wbp2, YBX1 and Nudt21.
Amot, AmotL1 and Wbp2, but not YBX1 and Nudt21,
were enriched in the S89A and TAZ precipitates as
compared with the WWm precipitates, suggesting that
they likely interact with TAZ in a WW domain-
dependent manner. As Wbp2 is known to interact with
YAP (Chen and Sudol, 1995), we characterized a
potential role for Wbp2 in TAZ regulation. To conﬁrm
that the interaction between Wbp2 and TAZ is
dependent on the WW domain of TAZ, we transiently
expressed wild-type Flag-TAZ, Flag-WWm as well as
Flag-S89A into 293 cells; whole-cell lysates were
immunoprecipitated with anti-Flag antibody and the
immunoprecipitates were tested for the presence of
Wbp2 by immunoblotting with anti-Wbp2 antibody.
Figure 2b shows that both TAZ and S89A efﬁciently
coimmunoprecipitated endogenous Wbp2, but WWm
failed to interact with Wbp2. To investigate whether
TAZ interacts with Wbp2 directly or through
other proteins, an in vitro binding assay was performed
using recombinant His-tagged Wbp2 (His-Wbp2) and
glutathione S-transferase (GST)-tagged TAZ (GST-TAZ).
When incubated together, His-Wbp2 can be recovered
with GST-TAZ, but not GST, by glutathione beads
(Figure 2c), suggesting that Wbp2 interacts with TAZ
directly. These results suggest that Wbp2 interacts with
TAZ directly in a WW domain-dependent manner.
The interaction of Wbp2 with TAZ is mediated by its
PPXY-containing C-terminal region
Alignment of amino-acid sequences of Wbp2 proteins
from different species shows that there are three PPXY
motifs, present in the C-terminal portion of Wbp2, and
that the second and third motifs are conserved among
various species such as human, zebraﬁsh, frog, worm
and ﬂy, whereas the ﬁrst motif is only conserved in some
species (Supplementary Figure S1, Figure 3a). PPXY
motifs have been shown to be important for binding to
WW domains (Chen and Sudol, 1995; Sudol et al., 1995;
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Figure 1 The WW domain of TAZ is important for its ability to confer anchorage-independent growth of MCF10A cells. (a) Soft
agar growth assays were done using MCF10A cells transduced with expressing vector (control), Flag-TAZ, Flag-S89A and Flag-
WWm. The colonies grown in soft agar after 1 month of culture were stained with thiazolyl blue tetrazolium bromide. (b) Lysates
derived from the cells were analyzed by immunoblotting using anti-Flag antibody. (c) The colony number was quantiﬁed from three
independent soft agar assays and presented as percentage relative to S89A, which is arbitrarily set as 100%. *Po0.05 versus TAZ.
(d, e) The relative transcript levels of ITGB2 and CTGF in MCF10A cells stably expressing S89A, TAZ and WWm were assessed by
real-time PCR. The relative expression level of ITGB2 and CTGF was presented as fold activation relative to vector control, which is
set as 1. *Po0.05 versus TAZ.
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et al., 1997; Harvey et al., 1999). To investigate whether
the PPXY motif-containing C-terminal portion of Wbp2
is important for interaction with TAZ, two truncation
mutants were created, one containing the N-terminal
region (amino acids 1–151) and the other containing the
C-terminal region (amino acids 137–261) (Figure 3a). As
the C-terminal fragment is very unstable and thus
undetectable, the full-length Wbp2, N-terminal and C-
terminal regions were expressed as a fusion protein with
green ﬂuorescent protein (GFP). When coexpressed with
Flag-TAZ, the full-length and the C-terminal region of
Wbp2 interacted with TAZ, but the N-terminal region
failed to interact (Figure 3b), suggesting that the PPXY
motif-containing C-terminal region of Wbp2 interacts
with the WW domain of TAZ. Owing to the fact that
GFP-WBP2-N-ter is expressed at much lower levels, its
lack of interaction is only indicative and thus should not
be interpreted alone. However, once the PPXY motifs at
the C terminal of Wbp2 are mutated, the interaction
between these PPXY mutants and TAZ is dramatically
reduced (Figure 3c). This suggests that the C-terminal
region of Wbp2 is most important for interaction with
TAZ, consistent with the lack of interaction of TAZ
with the GFP-WBP2-N-ter.
The PPXY motifs of Wbp2 are important for interaction
with the WW-domain of TAZ
As there are three PPXY motifs in the C-terminal
portion of human Wbp2, we next investigated their
relative importance in mediating interaction with TAZ.
The three motifs were mutated singly, doubly in various
combinations (1þ2, 1þ3o r2þ3), or triply (1þ2þ3)
to generate different PPXY mutants: PPXY1, PPXY2,
PPXY3, PPXY1þ2, PPXY1þ3, PPXY2þ3a n d
PPXY1þ2þ3. These PPXY mutants, along with
Flag-TAZ, were transiently expressed in 293 cells and
whole-cell lysates were immunoprecipitated with anti-
Flag antibody followed by immunoblotting analysis
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Figure 2 Direct interaction of Wbp2 with TAZ depends on the WW domain of TAZ. (a) Several PPXY motif-containing proteins
were identiﬁed by large-scale coimmunoprecipitation. A total of 293 cells expressing 3XFlag-6XHis-TAZ, -S89A and -WWm (together
with cells transfected with vector) were lysed and the lysates were processed for large-scale coimmunoprecipitation. The precipitates
were resolved by SDS–PAGE and the gel pieces were excised out for mass spectrometry (MS) analysis. The bands containing Amot,
AmotL1, TAZ, Wbp2 and their MS coverage of the polypeptide were indicated (left). The Wbp2 peptide sequencescovered are shown
(right). (b) WW domain of TAZ is required for interaction with Wbp2. Whole-cell lysates from 293 cells transiently expressing vector,
Flag-TAZ, Flag-S89A and Flag-WWm were immunoprecipitated with anti-Flag, and the immunoprecipitates (together with starting
lysate as input) were analyzed by immunoblot to detect coimmunoprecipitated endogenous Wbp2 (top). The blots were stripped and
re-probed with anti-Flag-HRP to detect immunoprecipitated Flag-TAZ and its mutants (bottom). Mutation of WW domain of TAZ
disrupted interaction with endogenous Wbp2. (c) Direct interaction of TAZ with Wbp2. GST sepharose containing equal amount of
GST-TAZ or GST proteins were incubated with puriﬁed His-tagged Wbp2 protein and washed. Proteins retained on the beads
were analyzed by immunoblot to detect Wbp2. His-Wbp2 is bound to GST-TAZ but not GST. (d) The puriﬁed His-Wbp2, GST and
GST-TAZ proteins resolved by SDS–PAGE gel.
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Oncogenewith anti-hemagglutinin (HA) antibody to detect the co-
recovery of these various HA-tagged mutant proteins.
Figure 3c shows that PPXY2 (lane 4), PPXY1þ2 (lane
6) and PPXY1þ2þ3 (lane 9) are severely impaired in
their property of being coimmunoprecipitated with
TAZ, whereas PPXY1 (lane 3), PPXY3 (lane 5) and
PPXY1þ3 (lane 7) seem to have a minor effect on the
interaction with TAZ. These results suggest that the
second PPXY motif of Wbp2 is most important for
interaction with TAZ, because its single mutation
reduced the interaction to a comparable level as the
mutation of all three motifs.
Knockdown of Wbp2 suppresses, whereas overexpression
of Wbp2 enhances, TAZ-driven transformation
After establishing the interaction of TAZ with Wbp2,
we then examined whether endogenous Wbp2 is
required for TAZ-mediated transformation. We sup-
pressed the expression of endogenous Wbp2 using a
short hairpin (sh)RNA knockdown approach. As the
Hippo-refractory S89A has enhanced ability to trans-
form MCF10A cells, we used it to test the role of
endogenous Wbp2 with S89A-mediated cell growth in
soft agar. Soft agar growth assay was performed using
MCF10A-S89A cells transduced with retroviral vector
expressing shRNAs (knockdown (KD) 1 and KD2) tar-
geting Wbp2. Both shRNAs noticeably reduced the
expression of Wbp2 protein as well as its transcript in
MCF10A cells, as veriﬁed by immunoblotting and
quantitative PCR (Figure 4a), and reduced the colony
numbers of S89A-expressing cells in soft agar (Figures
4b and c). Although Wbp2 itself did not have the ability
to induce soft-agar growth in MCF10A cells, over-
expression of Wbp2 enhanced TAZ-mediated transfor-
mation of MCF10A cells (Figures 4d and e). The
observations that knockdown of endogenous Wbp2
caused the reduction of soft agar colony number induced
by S89A and overexpression of Wbp2 enhanced TAZ-
mediated transformation strongly suggest that endogen-
ous Wbp2 is important for TAZ and its Hippo-refractory
S89A mutant to transform MCF10A cells.
Forced interaction of WWm with Wbp2 by direct fusion
of Wbp2 to the TAZ C-terminus restored/enhanced the
transforming ability
To conﬁrm that the reduction of transforming activity
of WWm is indeed due to the loss of interaction with
Wbp2, we generated a WWm–Wbp2 fusion protein by
directly joining the Wbp2 to the C-terminus of WWm.
As shown in Figures 5a–d, the WWm–Wbp2 fusion
protein not only has restored transforming ability but
also displayed a signiﬁcantly enhanced ability to trans-
form NIH3T3 cells. In fact the WWm–Wbp2 was as
oncogenic as the Hippo refractory S89A mutant. The
potent transforming ability exhibited by WWm–Wbp2
suggests that a reduction in the transforming ability of
WWm is likely caused by its lost interaction with Wbp2,
rather than by misfolding or conformation changes.
Furthermore, fusion of the PPXY motif-containing
C-terminal, but not the N-terminal portion of Wbp2,
with WWm restored and even enhanced the transform-
ing ability of TAZ (Figures 5a–c). Although PPXY
motif-mediated interaction with TAZ is important
for Wbp2 to potentiate the transforming ability of
TAZ, some other regions in the C-terminal domain
of Wbp2 may also be involved in the transforming
activity of TAZ. In addition, the ability to induce the
transcription of ITGB2 was also signiﬁcantly restored
for WWm when fused to Wbp2 or its C-terminal
region (Figure 5d). Taken together, these results suggest
that the interaction of TAZ with endogenous Wbp2
is important for TAZ to drive transcription and trans-
form cells.
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Figure 3 Interaction of Wbp2 with TAZ depends on the PPXY
motifs-containing C-terminal region of Wbp2. (a) The schematic
diagram shows the N-terminal, C-terminal regions of Wbp2 and
the positions of three PPXY motifs. (b) The C-terminal region of
Wbp2 is important for interaction with TAZ. Whole-cell lysates
from 293 cells transiently expressing Flag-TAZ together with GFP-
Wbp2, GFP-Wbp2-N-terminal or GFP-Wbp2-C-terminal regions
were immunoprecipitated with anti-Flag, and the immunoprecipi-
tates were analyzed by immunoblot to detect coimmunoprecipi-
tated GFP-Wbp2 and its mutants. The blots were stripped and
re-probed with anti-Flag-HRP to detect immunoprecipitated Flag-
TAZ. (c) PPXY motifs (aa197-200) of Wbp2 are important for
interaction with TAZ. In all, 293 cells expressing Flag-TAZ and
various mutants of HA-Wbp2 were processed for immunoprecipi-
tation. The immunoprecipitates were analyzed by immunoblot to
detect coimmunoprecipitated Wbp2 and its PPXY mutants.
Mutation of the second PPXY motif signiﬁcantly reduced the
ability of Wbp2 to interact with TAZ. Lane 1 is negative control for
immunoprecipitation with 293 cells expressing vector and wild-type
Wbp2 only.
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In this study, we showed that the WW domain of TAZ is
important for its oncogenic capability, as well as for its
ability to activate transcription of genes such as ITGB2
that are known to be upregulated by TAZ. Mutation of
the WW domain of TAZ reduced its transforming
ability as assessed by anchorage-independent cell growth
in soft agar. Our results are consistent with the ﬁnding
that the YAP WW domains are required for YAP to
transform NIH3T3 cells and for YAP’s ability to induce
ITGB2 (Zhao et al., 2009; Zhang et al., 2009b). We
observed no clear role for the TAZ WW domain in
mediating interactions with negative regulatory pro-
teins, although these could have been masked if the
observed positive regulatory interactions were epistatic
with respect to their inﬂuence on TAZ activity.
Increasing evidence shows that the WW domain of
Yorkie, YAP and TAZ interacts with multiple different
proteins containing PPXY motifs. Evidence from ﬂies
and from mammalian tissue culture studies suggest that
the WW domains of Yorkie and YAP interact with both
positive and negative regulatory proteins, and therefore
it is conceivable that some WW domain-interacting
proteins may also execute inhibitory effects on the
transforming ability of TAZ and YAP. As such, the
regulatory role of the Yorkie, YAP and TAZ WW
domains may depend on the cellular context and
experimental conditions that may alter the relative
abundance of PPXY-containing proteins that interact
with Yorkie, YAP and TAZ.
Among the proteins that were pulled down by TAZ
and S89A, but not by WWm, were PPXY motif-
containing Wbp2, Amot and AmotL1, implying that
these proteins interact with the WW domain of TAZ. As
WWm has reduced transforming ability, we explored the
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Figure 4 Suppression of Wbp2 expression inhibits, whereas overexpression of Wbp2 enhances TAZ-driven transformation of
MCF10A cells. (a) The relative protein and transcript levels of Wbp2 were assessed by immunoblot and real-time PCR, respectively.
The average level of Wbp2 transcript in vector-transduced cells is arbitrarily set at 1. *Po0.05 versus control. (b) S89A-driven
anchorage-independent growth is suppressed by shRNA-mediated knockdown of Wbp2. S89A-expressing MCF10A cells (S89A)
transduced with vector (control) or Wbp2 shRNAs (Wbp2-KD-1 or Wbp2-KD-2) targeting Wbp2 were grown in soft agar for a month
and colonies were stained. (c) Quantiﬁcation of soft agar colonies of S89A cells expressing Wbp2 shRNAs, the average from three
independent experiments was presented. The average colony number from S89A cells expressing no shRNA targeting Wbp2 is
arbitrarily set at 100%. *Po0.05 versus control. (d) Overexpression of Wbp2 enhances TAZ-driven transformation. MCF10A-vector
and MCF10A-TAZ cells cotransduced with Wbp2 were used to perform soft agar assays. (e) Quantiﬁcation of soft agar colonies from
(d) and presented as percentage relative to TAZþvector, which is arbitrarily set as 100%. *Po0.05 versus TAZþcontrol.
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domain for transforming ability and gene regulation.
Consistent with this hypothesis, we provided evidence
showing that Wbp2 interacts directly with TAZ and this
interaction is likely mediated by the WW domain of
TAZ and the second PPXY motif of Wbp2. The
functional consequence of this interaction was then
established by our observations that the potent trans-
forming ability of S89A is suppressed by knockdown of
endogenous Wbp2 and the moderate transforming
ability of wild-type TAZ is noticeably enhanced by
exogenous Wbp2, supporting a role of Wbp2 in
positively regulating the transforming ability of TAZ.
Further support for a role of Wbp2 came from the
results that the defect of transforming ability of WWm
can be rescued by fusing Wbp2 or its C-terminal region
to the C-terminus of WWm. In addition, these fusion
proteins displayed enhanced transforming ability, sug-
gesting that the physical interaction of Wbp2 with TAZ
may signiﬁcantly empower the transforming potential of
TAZ. Furthermore, mutation of the WW domain of the
Hippo refractory S89A also reduced its transforming
activity, whereas fusion of full-length Wbp2 to the
S89A-WWm restored the activity (Supplementary Fig-
ure S2). This suggests that Wbp2 interaction with the
WW domain is also involved in the much enhanced
transforming activity of S89A. The enhanced transform-
ing ability could possibly be explained by the fact that
TAZ and Wbp2 would now be constitutively associated
and, therefore, Wbp2 would not be subject to competi-
tion with other PPXY motif-containing proteins
(especially negatively regulatory proteins) for the TAZ
WW domain.
As Wbp2 is also a YAP interacting factor (Chen
and Sudol, 1995), we have examined whether it can
enhance the transforming ability of YAP. We ﬁrst
created mutant YAP having the ﬁrst (YAP-WW1m),
the second (YAP-WW2m) or both (YAP-WW(1þ2)m)
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Figure 5 Direct fusion of full-length Wbp2 and its C-terminal, but not N-terminal region, to WWm restore the transforming and
gene-induction abilities of TAZ. (a) NIH-3T3 cells stably expressing the indicated constructs grown on soft agar are shown. (b) Lysates
derived from cells expressing the indicated constructs were analyzed by immunoblotting using anti-Flag antibody (left) and anti-HA
antibody (right). (c) Quantiﬁcation of colony numbers for all the indicated constructs in comparison with vector-transduced cells. The
average number derived from S89A-expressing cells is arbitrarily set at 100%. Po0.05 versus TAZ. (d) The relative expression levels of
ITGB2 in MCF10A cells stably expressing the indicated constructs were assessed by real-time PCR. *Po0.05 versus TAZ.
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OncogeneWW domains mutated and examined their transforming
ability (Supplementary Figure S3). In our study, muta-
tion of WW1, WW2 or both WW domains enhanced the
transforming ability of YAP in both NIH3T3 and
MCF10A cells as compared with wild-type YAP. These
results are different from those reported by Guan’s
group, where mutations of WW domains of YAP
reduced NIH3T3 cell growth in soft agar (Zhao et al.,
2009), and those by Harvey’s group, where YAP WW
domain mutants reduce NIH3T3 cell growth but
enhance MCF10A cell growth in soft agar (Zhang
et al., 2009b). Although this issue remains to be further
investigated, one possible explanation is that the
WW domains of YAP are primarily interacting
with negative factors under our experimental conditions
in both NIH3T3 and MCF10A cells. Importantly, when
Wbp2 was fused directly to the C terminus of these YAP
mutants to create YAP-WW1m-Wbp2, YAP-WW2m-
Wbp2 and YAP-WW(1þ2)m-Wbp2, these fusions
induced more NIH3T3 and MCF10A cell growth in
soft agar as compared with their respective WW domain
mutants (Supplementary Figure S3), suggesting that
Wbp2 potentiates YAP transforming activity. These
results suggest that physical interaction of Wbp2 with
YAP also has a positive effect on its transforming
ability.
YAP and TAZ are able to induce EMT and increase
cell proliferation (Overholtzer et al., 2006; Lei et al.,
2008; Zhang et al., 2009a,b). Moreover, WW domains
of YAP are essential for the increased cell proliferation,
but dispensable for EMT (Zhao et al., 2009). We have
also examined the relevance of the WW domain of TAZ
and its interaction with Wbp2 in EMT and cell
proliferation. The expression of EMT markers was
examined to investigate the role of TAZ WW domain
and its interaction with Wbp2 (Supplementary Figure
S4A). In our study, the alterations of EMT markers are
not as clear-cut as reported, although the general trend
holds true. The expression of epithelial marker E-
cadherin was suppressed mostly in MCF10A cells
expressing S89A. E-cadherin downregulation was no-
ticeable but only moderate in cells expressing TAZ,
WWm, WWm-Wbp2 and WWm-Wbp2-C-ter, whereas
cells expressing WWm-Wbp2-N-ter had similar levels of
E-cadherin as vector-transduced cells. Consistently,
vimentin is mostly upregulated in cells expressing
WWm-Wbp2-C-ter and S89A. Signiﬁcant vimentin
upregulation was also observed upon overexpression
of TAZ, WWm and WWm-Wbp2, but not WWm-
Wbp2-N-ter. Furthermore, S89A and WWm-Wbp2-C-
ter are relatively more potent in inducing the expression
of ﬁbronectin and, to a lesser extent, N-cadherin. The
ability of WWm to induce the expression of some EMT
markers is similar to TAZ and WWm-Wbp2. These
results indicate that WW domain is not very crucial for
EMT, although S89A and Wwm-Wbp2-C-ter have
enhanced ability to induce EMT. Our results are
consistent with the earlier observation that the WW
domain of YAP is not very crucial for EMT (Zhao et al.,
2009). Furthermore, cell proliferation assays show that
the WW domain of TAZ (Supplementary Figure S4B)
and cellular Wbp2 (Supplementary Figure S4C) are
both positively involved in cell proliferation.
Consistent with the notion that the role of the WW
domains of TAZ and YAP depends on the relative
abundance and interacting afﬁnity of various PPXY
motif-containing proteins, our preliminary analysis
indicates that Amot also interacts with the WW domain
of TAZ and YAP and that this interaction seems to
suppress the transforming ability of TAZ and YAP. As
such, if the positive PPXY motif-containing proteins
such as Wbp2 are more dominant in the cell under a
certain condition, then the WW domain is important for
the transforming ability. On the other hand, if the
negative PPXY motif-containing proteins such as Amot
are dominant, then the WW domain is involved in
suppressing the transforming ability of TAZ and YAP.
Future studies will provide better understanding about
this hypothesis. The mechanism by which Wbp2
regulates TAZ-mediated transformation and gene ex-
pression is currently unknown. HA-Wbp2 is distributed
both in the cytoplasm and in the nucleus (Supplemen-
tary Figure S5A) as assessed by immunoﬂuorescence
microscopy. When Flag-TAZ was expressed alone or
together with Wbp2, TAZ is preferentially distributed in
the nucleus and coexpressed Wbp2 does not have a
signiﬁcant effect on the localization of TAZ (Supple-
mentary Figure S5B). Furthermore, overexpression of
Wbp2 does not affect the phosphorylation or abundance
of TAZ (Supplementary Figure S5C) and increase in the
amount of Wbp2 does not affect the interaction of TAZ
with TEAD4 (Supplementary Figure S6). Therefore, the
mechanism underlying Wbp2 action needs to be further
deﬁned. A previous study has suggested that it interacts
with E6-AP to promote transcriptional activation of
estrogen and progesterone receptors (Dhananjayan
et al., 2006). The transcriptional activation of progester-
one receptor by Wbp2 may be mediated by the
recruitment of YAP. It was shown that the third
Wbp2 PPXY motif is most important. One possibility
is that via Wbp2, other proteins such as E6-AP may be
recruited to TAZ-containing complexes in such a way
that transcription of selected genes such as ITGB2 is
positively regulated. How the interaction of Wbp2 with
TAZ is regulated is another interesting issue because it
was reported that Wbp2 is tyrosine-phosphorylated in
response to the stimulation by epidermal growth factor
in MCF10A cells (Chen et al., 2007). It will be
interesting to examine whether Tyr-phosphorylation of
Wbp2 can regulate its interaction with TAZ and
transcriptional outcome. Future studies addressing these
issues will provide additional insights into the molecular
mechanism by which TAZ and Wbp2 coordinately
control transcription and cell transformation.
Materials and methods
Cell lines and materials
MCF10A and NIH-3T3 cells were purchased from the American
Type Culture Collection. MCF10A cells were cultured in
Dulbecco’s modied Eagle’s medium supplemented with 5%
Wbp2 mediates oncogenic growth of TAZ
SW Chan et al
607
Oncogenehorse serum, 20ng/ml of epidermal growth factor, 0.5mg/ml
of hydrocortisone, 100ng/ml of cholera toxin and 10mg/ml
of insulin and pen/strep. NIH-3T3 cells were cultured in
Dulbecco’s modied Eagle’s medium supplemented with 10%
fetal bovine serum. Protease inhibitors cocktail was purchased
from Roche Diagnostics Corporation (Roche Applied Science,
Indianapolis, IN, USA). Ezview Red anti-Flag M2 afﬁnity
gel and 3XFLAG peptide were from Sigma-Aldrich (St Louis,
MO, USA). Talon cobalt resin was from Clontech Labora-
tories, Inc. (Mountain View, CA, USA).
Antibodies
Wbp2 antibody was purchased from Abnova (Taiwan)
Corporation (Taipei City, Taiwan), which recognizes endo-
genous Wbp2 as well as overexpressed HA-Wbp2 in MCF10A
(Supplementary Figure S7). The endogenous Wbp2 exhibited
an apparent size of B42kDa in our system (left lane),
although the predicted size of Wbp2 is about 28kDa. The
much enhanced size of the HA-Wbp2 (right lane) in the same
experiment is supportive of the apparently oversized Wbp2 in
the SDS–PAGE. EZview Red anti-Flag M2 afﬁnity gel and
anti-Flag M2-peroxidase (anti-Flag-horseradish peroxidase)
mouse antibody were from Sigma. Anti-GFP was from Upstates
Biotechnology (Millipore Corporate Headquarters, Billerica,
MA, USA). Anti-HA-peroxidase (anti-HA-horseradish peroxidase)
antibody was from Roche.
Plasmids
Flag-TAZ and S89A were previously described (Chan et al.,
2008, 2009). Double amino-acid mutations were introduced
into W152 and P155 of TAZ to create WWm (W152A, P155A)
by PCR. Wbp2 complementary DNAs were obtained from
MegaMan Human Trinscriptome Library (Stratagene (Agilent
Technologies, Inc.), Santa Clara, CA, USA) using PCR,
tagged with HA epitope at the N-terminus and cloned into
pBABEpuro retroviral vector. PCR-ampliﬁed complementary
DNA fragments coding for full length, the N terminal and the
C terminal of Wbp2 were subcloned into pEGFP (Clontech) to
make GFP-Wbp2, GFP-Wbp2-N-ter and GFP-Wbp2-C-ter.
GST fusion proteins were prepared as described previously
(Chan et al., 2008). WWm-Wbp2, WWm-Wbp2-N-ter and
WWm-Wbp2-C-ter were constructed by fusing the full-length
WWm coding region to the second codon of Wbp2, Wbp2
(amino acids 2–151) and Wbp2 (amino acids 137–261),
respectively. TAZ was subcloned into pGEX-4T vector
(Pharmacia, GE Healthcare Bio-Sciences AB, Uppsala,
Sweden) to make GST-TAZ and Wbp2 was subcloned into
pET-32 (modiﬁed) from Naiyang Fu, Singapore, to make His-
Wbp2. Alanines were introduced to the Y residue of the PPXY
motifs of the Wbp2-PPXY mutants by PCR. 3XFlag-6XHis-
TAZ, -S89A and -WWm were cloned into pCIneo (Promega
Corporation, Madison, WI, USA) vector. The sequence of the
3XFlag-6XHis is 50-ATGGACTACAAAGACGATGACGA
CAAGGACTACAAAGACGATGACGACAAGGACTACAA
AGACGATGACGACAAGCATCATCACCATCACCAT-30.
Retrovirus generation and infection
The amphotropic and ecotropic Phoenix packaging cells
(kindly provided by Nolan Lab at Stanford University) were
transfected with the indicated retroviral vectors using
Lipofectamine according to the manufacturer’s instruction
(Invitrogen, Carlsbad, CA, USA). After 48h, the retroviral
supernatants were collected, ﬁltered (0.45mm; Millipore
Corporate Headquarters, Billerica, MA, USA) and added
onto the target cells in the presence of 5mg/ml of polybrene
(Sigma-Aldrich) for 6–8h. Infection was done twice. After
infection, the cells were selected with puromycin (1mg/ml) for
a week before being analyzed for protein expression by
immunoblotting, followed by soft agar assays. If two
constructs were expressed in the cells, the transductions were
done sequentially and the cells were selected with two different
antibiotics, hygromycin and puromycin.
Anchorage-independent growth in soft agar
In all, 1.5ml of 0.5% agar (electrograde ultra pure; Invitrogen)
supplemented with culture media was plated in six-well plates
as the bottom agar. Thirty thousand cells were mixed with
1.5ml of 0.35% agar-supplemented media and plated on the
solidiﬁed bottom agar. The media (of volume 1ml) was added
on top of the solidiﬁed agar layers and the colonies were
allowed to grow in an incubator at 371C, 5% CO2 for a month
for MCF10A cells and 2 weeks for NIH-3T3 cells. The
colonies were stained with thiazolyl blue tetrazolium bromide
and scanned. Colonies were quantiﬁed using Image J program
developed at National Institutes of Health (NIH), USA.
RNA isolation and real-time PCR
Total RNA was isolated from culture cells using RNeasy
Mini Kit form QIAGEN Sciences (Germantown, MD, USA).
Complementary DNA was synthesized by reverse transcrip-
tion using High Capacity complementary DNA Reverse
Transcription Kit (Applied Biosystems) and subjected to
real-time PCR using speciﬁc probes and reagents from Applied
Biosystems. Relative abundance of mRNA was calculated
using a program provided by Applied Biosystems (Life
Technologies Corporation, Carlsbad, CA, USA).
shRNA-mediated knockdown of Wbp2
The sequences of the shRNAs against human Wbp2 were KD-
1, 50-AACGTGCCAGAAGCCTTCAAA-30, and KD-2, 50-GC
GGAGTGATCGTCAATAA-30. The shRNAs were cloned
into retroviral vector pSuper.retro.puro vector (Oligoengine,
Seattle, WA, USA). The relative amount of protein and
transcripts for Wbp2 was assessed by immunoblotting as well
as real-time PCR using reagents from Applied Biosystems.
Immunoprecipitation
Human embryonic kidney cells 293 (in a 10-cm plate)
transiently transfected with the indicated plasmids were
washed once with ice-cold phosphate buffered saline and
subsequently lysed in 1ml of ice-cold lysis buffer (150mM
NaCl, 50mM Tris–HCl, pH 7.4, 0.1% NP40 and protease
inhibitor cocktail (Roche)). After clearance by a spin (10000g,
15min), 1mg of whole cell lysates was incubated overnight
with 70ml of Ezview Red anti-Flag M2 afﬁnity gel, washed
twice with 1ml of lysis buffer with 500mM NaCl and 0.5%
NP40 followed by three times with lysis buffer, and ﬁnally
resolved on SDS–polyacrylamide gels and blotted onto
nitrocellulose membrane. The ﬁlters were blocked with 5%
skimmed milk in phosphate buffered saline and probed with
anti-HA-horseradish peroxidase (50ng/ml), anti-Wbp2 (1:500)
or anti-GFP (1:1000) antibodies. Signals were visualized using
Supersignal (Pierce Biotechnology (Thermo Fisher Scientiﬁc),
Rockford, IL, USA). The blots were stripped and re-probed
with anti-Flag-horseradish peroxidase (1:1000) to detect
immunoprecipitated Flag-TAZ.
Identiﬁcation of interacting proteins of TAZ
293 cells transiently expressing the Flag(3X) and His(6X)
tagged TAZ, S89A and WWm were used for large-scale
immunoprecipitation. In all, 50mg of whole cell lysates in lysis
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Oncogenebuffer (50mM Tris, pH 7.4, 150mM NaCl, 0.1% NP40 and
protease inhibitors cocktail) was incubated overnight with 1ml
of EZview Red anti-Flag M2 afﬁnity gel at 41C. The beads
were then washed two times with lysis buffer with 500mM
NaCl and 0.5% NP40 and three times with lysis buffer. The
proteins were eluted with one bed volume of 1.25mg/ml 3X
FLAG peptide in 50mM Tris–HCl, pH 7.5 and 150mM NaCl
for three times and eluates were incubated overnight with
150ml bed volume of Talon cobalt resin. The resin was then
washed ﬁve times with buffer containing 50mM Tris, 150mM
NaCl and 50mM immidazole and subsequently eluted
with 50mM Tris, 150mM NaCl and 300mM immidazole. The
eluates were ﬁnally incubated with 10% trichloroacetic acid to
precipitate the associated proteins overnight at  201C and
the protein pellets were washed twice with ice-cold acetone
and dried.
Mass spectrometry and data analysis
Eluted protein complexes were separated by 1D SDS–PAGE
and digested with trypsin using minor variants on published
procedures (Shevchenko et al., 2006). Samples were analyzed
on an Orbitrap Classic (Thermo Fisher Scientiﬁc, Rockford,
IL, USA). Survey full scan mass spectrometry (MS) spectra
(m/z 400–1400) were acquired with a resolution of R¼60000
at m/z 400, an AGC target of 1e6 ions, and a maximum
injection time of 500ms. The 10 most intense peptide ions in
each survey scan with an ion intensity above 1000 counts and a
charge state X2 were sequentially isolated to a target value of
1e4 and fragmented in the linear ion trap by collisionally
induced dissociation (CID/CAD) using a normalized collision
energy of 35%. A dynamic exclusion was applied using a
maximum exclusion list of 500 with one repeat count, repeat
and exclusion duration of 45 and 30s, respectively. All MS/MS
samples were analyzed using Mascot (Matrix Science,
London, UK, version 2.0). Mascot was set up to search the
IPI.HUMAN.v3.32 database (71844 sequences) assuming the
digestion enzyme trypsin. A fragment ion mass tolerance of
0.40Da and a parent ion tolerance of 5p.p.m. were used.
Iodoacetamide derivative of cysteine was speciﬁed as a ﬁxed
modiﬁcation. Pyro-glu from E of glutamic acid, pyro-glu from
Q of glutamine, deamidation of asparagine, oxidation of
methionine and acetylation of the N-terminus were speciﬁed
as variable modiﬁcations. Scaffold (version Scaffold_2_05_02,
Proteome Software Inc, Portland, OR, USA) was used to
validate MS/MS-based peptide and protein identiﬁcations.
Statistics
Statistical signiﬁcance was assessed by Student’s t-test. A
P-value less than 0.05 was considered to be statistically
signiﬁcant.
Other materials and methods
They are described as Supplementary information.
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